Frankfurt - Delayed Quote EUR
Bicycle Therapeutics plc (50BA.F)
8.45
+0.75
+(9.74%)
At close: May 5 at 11:19:35 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,722
35,275
26,976
14,463
11,697
Operating Expense
273,093
244,428
216,328
131,116
77,315
Operating Income
-247,371
-209,153
-189,352
-116,653
-65,618
Net Non Operating Interest Income Expense
36,114
32,554
10,739
2,412
-2,864
Other Income Expense
2,533
2,803
-594
-555
358
Pretax Income
-208,724
-173,796
-179,207
-114,241
-68,482
Tax Provision
-5,502
-4,765
1,457
-1,524
-1,663
Net Income Common Stockholders
-203,222
-169,031
-180,664
-112,717
-66,819
Diluted NI Available to Com Stockholders
-203,222
-169,031
-180,664
-112,717
-66,819
Basic EPS
-3.16
-2.90
-5.08
-3.80
-2.67
Diluted EPS
-3.16
-2.90
-5.08
-3.80
-2.67
Basic Average Shares
64,866.81
58,207.59
35,592.36
29,660.66
25,061.73
Diluted Average Shares
64,866.81
58,207.59
35,592.36
29,660.66
25,061.73
Total Operating Income as Reported
-248,360
-209,872
-189,946
-116,653
-65,618
Total Expenses
273,093
244,428
216,328
131,116
77,315
Net Income from Continuing & Discontinued Operation
-203,222
-169,031
-180,664
-112,717
-66,819
Normalized Income
-201,330.22
-167,403.17
-180,182.86
-112,717
-66,819
Interest Income
37,074
34,284
14,002
5,756
120
Interest Expense
960
1,730
3,263
3,344
2,984
Net Interest Income
36,114
32,554
10,739
2,412
-2,864
EBIT
-207,764
-172,066
-175,944
-110,897
-65,498
EBITDA
-200,614
-164,892
-169,398
-107,208
-64,089
Reconciled Depreciation
7,150
7,174
6,546
3,689
1,409
Net Income from Continuing Operation Net Minority Interest
-203,222
-169,031
-180,664
-112,717
-66,819
Total Unusual Items Excluding Goodwill
-1,943
-1,673
-594
--
358
Total Unusual Items
-1,943
-1,673
-594
--
358
Normalized EBITDA
-198,671
-163,219
-168,804
-107,208
-64,089
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-51.22
-45.17
-112.86
--
--
12/31/2021 - 5/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
HQ1.MU Oruka Therapeutics Inc. R
9.20
+1.10%
22Z.SG Zealand Pharma A/S
64.86
+4.55%
GNRO.PA GeNeuro SA
0.0700
+8.36%
OCD1.MU ChromaDex Corp
7.10
+5.19%
NXOA.BE Nicox SA
0.2330
+6.15%
GON.DU Geron Corp
1.2605
-1.37%
IXI.L IXICO plc
9.00
0.00%
PI3.DU Gubra AS
53.85
-0.28%
APE1.SG Addex Therapeutics Ltd
6.25
-5.30%